Autotransfusion Group Of Arkansas LLC

Autotransfusion Group of Arkansas LLC is a woman-owned small business headquartered in Sherwood, Arkansas, that specializes exclusively in providing autologous transfusion and cell saver blood recovery services to the federal government. The company is a for-profit limited liability corporation registered in SAM.gov since May 2020, with active federal contracting status through July 2026. Autotransfusion Group of Arkansas LLC has established itself as a specialized medical services provider focused on blood conservation techniques that support surgical procedures for veteran patients across the Veterans Health Administration system.

The company has demonstrated a sustained contracting relationship with the Department of Veterans Affairs, specifically Veterans Integrated Service Network 16 (VISN 16), with six delivery orders awarded between October 2020 and October 2025. These delivery orders, valued between approximately $47,875 and $140,450, have been issued on a firm fixed-price basis with no socioeconomic set-asides applied despite the contractor's woman-owned small business status. The services provided include onsite auto-transfusion services and cell saver blood recovery procedures performed at VA medical facilities in Arkansas, including locations in Little Rock, North Little Rock, and Sherwood. All contracts have been structured as delivery orders issued against indefinite delivery vehicles, enabling the VA to procure these specialized medical services on an as-needed basis. The performance periods have consistently aligned with fiscal years or portions thereof, with ultimate completion dates ranging from April 2023 through September 2026, reflecting the ongoing operational nature of these blood conservation services at VA medical centers.

Autotransfusion Group of Arkansas LLC currently holds a single-award indefinite delivery contract with the Department of Veterans Affairs, Veterans Integrated Service Network 16, valued at $646,022 with an award date of May 1, 2023, and an ultimate completion date of April 30, 2028. This IDV provides autologous transfusion and cell saver blood recovery services for VA medical facilities within VISN 16's service area, specifically supporting the Central Arkansas Veterans Healthcare System medical center. Multiple delivery orders have been issued against this vehicle since its award, including orders valued at $89,332 for May through September 2023, $135,340 for October 2023 through September 2024, $114,745 for October 2024 through September 2025, and $140,450 for October 2025 through September 2026. The contract was designated as a total small business set-aside and was issued as a single-award vehicle, indicating the VA's confidence in the contractor's specialized capabilities and its establishment as the sole provider of these critical perioperative blood conservation services across its Arkansas medical facilities.

The Cell Saver autotransfusion system is intended for use in surgeries in which medium- to high-volume blood loss occurs in order to return healthy red blood cells back to the patient that they have lost during the procedure. The system delivers moderate hematocrit (red blood cell concentration) and helps to remove traces of undesirable components, such as free hemoglobin, and is a critical tool in helping you avoid unnecessary allogeneic transfusions. There are a number of benefits of this, but returning fulling oxygenated blood back to the patient increases healing rate, lowers risk of infection and eliminates risk of rejection of donor blood for the volume of the autologous blood that they receive from our machine.